J. Chad Hoyle

J. Chad Hoyle's research focuses on neuromuscular and neurodegenerative disorders, particularly Friedreich ataxia (an inherited condition causing progressive nerve and muscle damage), myasthenia gravis (an autoimmune disorder affecting muscle strength), and peripheral neuropathies (nerve damage causing weakness or numbness). Much of the work involves clinical trials, natural history studies, and quality-of-life assessments for treatments like omaveloxolone and eculizumab. This research is largely clinically oriented, drawing on patient cohorts and case series to understand disease progression and treatment effects.

Publication output peaked around 2019 and has generally slowed over the past few years, averaging under two papers annually in the most recent five-year period.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026